Washington, 20 July 2024: Boehringer Ingelheim will sell an unbranded version of AbbVie's reference drug at a 92% discount to gain traction in the Humira (adalimumab) biosimilar market.

Patients will be able to purchase adalimumab-adbm exclusively through GoodRx, an on......
View Details

Related News

• Authorities Seize Counterfeit Medicines in UP Raid (20-01-2025)

---

• Illegal Performance-Enhancing Drugs Seized in Hyderabad Gym Raid (20-01-2025)

---

• EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 (20-01-2025)

---

• IPC to host 'World Pharmacopoeia meet' next month (20-01-2025)

---

• Immuneel Therapeutics launches low cost treatment for blood cancer (20-01-2025)

---

• Video clip of IIT Madras Director Kamakoti favouring 'Gomutra' goes viral (20-01-2025)

---

• Puducherry scientist develops high-yielding pepper variety (19-01-2025)

---

• Pharma firm raided in Baddi by ANTF again (19-01-2025)

---

• 2.70 lakh Narcotic Pills recovered in Sirsa, driver detained, handed over to DCO (19-01-2025)

---

• Arrest warrant for Baba Ramdev and Balakrishna (19-01-2025)

---